{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02987413",
      "OrgStudyIdInfo": {
        "OrgStudyId": "HospitalMCG"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "IEPSaoLucas",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "IEP Sao Lucas"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Hospital e Maternidade Dr. Christóvão da Gama",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients",
      "OfficialTitle": "Safety and Efficacy of Mesenchymal Stem Cells Escalated Application in Amyotrophic Lateral Sclerosis Patients: Study Design of a Phase I Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 28, 2015",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2016",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 5, 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "July 1, 2016",
      "StudyFirstSubmitQCDate": "December 8, 2016",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 9, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 4, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 7, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hospital e Maternidade Dr. Christóvão da Gama",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "IEP São Lucas - Instituto de Ensino e Pesquisa",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Clinica Jordy Sinapse",
            "CollaboratorClass": "UNKNOWN"
          },
          {
            "CollaboratorName": "TECHLIFE - Centro de Tecnologia Celular",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that selectively affects motor neurons in the brain and spinal cord, leading to bulbar, respiratory, and limb weakness. There is no effective treatment, and the disease usually progresses to death within 2 to 4 years. The therapeutic plasticity of mesenchymal stem cells (MSCs) may be an attractive therapy to this complex disease, turning MSCs strong candidates for cellular therapy in ALS.\n\nDesign-A phase 1 open-safety clinical trial. 4 patients will be selected according to a restricted inclusion and exclusion criteria and after 2 escalated infusions of MSCs, there will be a follow up period of one year Methods - Primary endpoint: safety of mesenchymal autologous stem cells infusions escalated in two intrathecal administrations in patients with ALS defined as severe adverse events (SAe). Secondary endpoints: clinical response, laboratorial and magnetic resonance imaging of patients submitted to cellular escalating doses applied in the study. Quality of life, according to El Escorial criteria, ALSFR scale and functional scales.\n\nConclusion: This study is a primary step before a large randomized double-blind clinical trial for ALS. It is expected to confirm the safety of escalated MSCs therapy in ALS patients, initial data of efficacy in addition to improved quality of life."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Motor Neuron Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Amyotrophic Lateral Sclerosis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "3",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Autologous Mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Two escalated intrathecal infusions of autologous mesenchymal stem cell",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous Mesenchymal stem cells (MSCs)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Mesenchymal stem cells (MSCs)",
            "InterventionDescription": "2 intrathecal autologous MSCs infusions (1x10^8 cells) will be performed, escalated from 30 days apart",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Autologous Mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Serious Adverse Events related to the treatment",
            "PrimaryOutcomeDescription": "Serious Adverse Events (Death, Life-threatening, Disability or Permanent Damage) will be monitored and documented during follow up",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Revised ALS Functional Rating Scale (ALSFRS-R)",
            "SecondaryOutcomeDescription": "Quality of life from patients according to functional scales will be evaluated before and after interventions with 1, 3, 6 and 12 months.",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nWomen and males over 18-year-old.\nDiagnosis of ALS in agreement with the criteria of \"EL SCORE\"\nLess than 24 months of evolution of the disease (from the beginning of the symptoms).\nGood understanding of the protocol and aptitude to grant the informed consent\nInfertile women (post-menopause or hysterectomized)\nBrazilian citizen and permanent resident.\n\nExclusion Criteria:\n\nAny significant medical condition (congestive heart failure, angina, respiratory failure, and others)\nAny auto-immune disease\nAny malignant diseases\nSystemic infection\nMental illness\nDepressive state",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Leandro B Agati, PhD",
            "OverallOfficialAffiliation": "Hospital e Maternidade Dr Christovao da Gama",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Eliseo J Sekiya, MD, PhD",
            "OverallOfficialAffiliation": "Instituto de Ensino e Pesquisas - IEP-São Lucas",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Adelson A Silva, MD",
            "OverallOfficialAffiliation": "Instituto de Ensino e Pesquisas - IEP-São Lucas",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Andresa Forte, MSc",
            "OverallOfficialAffiliation": "TECHLIFE - Centro de Tecnologia Celular",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Sergio S Jordy, MD",
            "OverallOfficialAffiliation": "Clínica Jordy Sinapse",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital e Maternidade Dr Christovao da Gama",
            "LocationCity": "Santo Andre",
            "LocationState": "Sao Paulo",
            "LocationZip": "09030010",
            "LocationCountry": "Brazil"
          },
          {
            "LocationFacility": "Instituto de Ensino e Pesquisas - IEP-São Lucas",
            "LocationCity": "Sao Paulo",
            "LocationState": "SP",
            "LocationZip": "01236-030",
            "LocationCountry": "Brazil"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Institutional website",
            "SeeAlsoLinkURL": "http://www.hmcg.com.br"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000016472",
            "ConditionMeshTerm": "Motor Neuron Disease"
          },
          {
            "ConditionMeshId": "D000000690",
            "ConditionMeshTerm": "Amyotrophic Lateral Sclerosis"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000019636",
            "ConditionAncestorTerm": "Neurodegenerative Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009468",
            "ConditionAncestorTerm": "Neuromuscular Diseases"
          },
          {
            "ConditionAncestorId": "D000013118",
            "ConditionAncestorTerm": "Spinal Cord Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000057177",
            "ConditionAncestorTerm": "TDP-43 Proteinopathies"
          },
          {
            "ConditionAncestorId": "D000057165",
            "ConditionAncestorTerm": "Proteostasis Deficiencies"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18031",
            "ConditionBrowseLeafName": "Motor Neuron Disease",
            "ConditionBrowseLeafAsFound": "Motor Neuron Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3176",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M20711",
            "ConditionBrowseLeafName": "Neurodegenerative Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11563",
            "ConditionBrowseLeafName": "Neuromuscular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15067",
            "ConditionBrowseLeafName": "Spinal Cord Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27912",
            "ConditionBrowseLeafName": "TDP-43 Proteinopathies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27900",
            "ConditionBrowseLeafName": "Proteostasis Deficiencies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4699",
            "ConditionBrowseLeafName": "Primary Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T349",
            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}